Myrexis, Inc.
Other OTCTotal Valuation
Myrexis, Inc. carries a market capitalization of 27,583.00, placing it among publicly traded companies globally.
| Market Cap | 27,583.00 |
| Enterprise Value | N/A |
Share Statistics
Myrexis, Inc. currently has 34.48M shares outstanding.
| Shares Outstanding | 34.48M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.02 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | -0.16 |
| P/OCF Ratio | -0.16 |
Financial Position
Myrexis, Inc. maintains a current ratio of 16.72, meaning it holds 16.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 16.72 |
| Quick Ratio | 16.35 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -25.02 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Myrexis, Inc.'s stock has gained approximately 300.00001% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 300.00001% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -11.60M, while operating income came in at -11.99M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -11.99M |
| Pretax Income | -8.20M |
| Net Income | -11.62M |
| EBITDA | -11.60M |
| EBIT | -11.99M |
| Earnings Per Share (EPS) | -0.42 |
Balance Sheet
Total book value stands at -128.14M, with working capital of 1.16M providing operational flexibility.
| Cash & Cash Equivalents | 1.21M |
| Total Debt | N/A |
| Net Debt | -1.13M |
| Equity (Book Value) | -128.14M |
| Book Value Per Share | -4.60 |
| Working Capital | 1.16M |
Cash Flow
Myrexis, Inc. produced -12.97M in operating cash flow over the past twelve months.
| Operating Cash Flow | -12.97M |
| Capital Expenditures | N/A |
| Free Cash Flow | -12.97M |
| FCF Per Share | -0.47 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 3,681.11 |
| FCF Yield | -620.56 |
Scores
Myrexis, Inc. posts an Altman Z-Score of -159.33, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -159.33 |